EUVIMEDEUVIMED entdecken
Crossref

Oral administration of Setanaxib delays osteoarthritis progression in a DMM murine model.

Félix Renaudin, Elodie Zocola, Cynthia Diabanza, Zohra Bouchemla, Thomas Laumonier, Didier Hannouche

Osteoarthritis and Cartilage · 2026-04 · 34 · S55

DOI: 10.1016/j.joca.2026.01.049 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Osteoarthritis and Cartilage, 2026-04. Verfasst von Félix Renaudin und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Renaudin, F., Zocola, E., Diabanza, C., Bouchemla, Z., Laumonier, T., & Hannouche, D. (2026). Oral administration of Setanaxib delays osteoarthritis progression in a DMM murine model. Osteoarthritis and Cartilage, 34, S55. https://doi.org/10.1016/j.joca.2026.01.049

Vancouver

Renaudin F, Zocola E, Diabanza C, Bouchemla Z, Laumonier T, Hannouche D. Oral administration of Setanaxib delays osteoarthritis progression in a DMM murine model. Osteoarthritis and Cartilage. 2026;34:S55. doi:10.1016/j.joca.2026.01.049

BibTeX
@article{Renaudin2026,
  author = {Renaudin, Félix and Zocola, Elodie and Diabanza, Cynthia and Bouchemla, Zohra and Laumonier, Thomas and Hannouche, Didier},
  title = {Oral administration of Setanaxib delays osteoarthritis progression in a DMM murine model},
  journal = {Osteoarthritis and Cartilage},
  year = {2026},
  volume = {34},
  pages = {S55},
  doi = {10.1016/j.joca.2026.01.049}
}
Kostenlos starten →